We Give Shareholders a Voice

Pernix Therapeutics Holdings, Inc. Information Request Form

Levi & Korsinsky announces it has commenced an investigation of Pernix Therapeutics Holdings, Inc. (NasdaqGM: PTX) concerning possible breaches of fiduciary duty by its Board of Directors. In particular, we determined that since February 5, 2014, the Company granted the CEO approximately 1,500,000 in-the-money options, valued at approximately $2 million, in violation of Company’s shareholder-approved executive compensation plan.  We are investigating an action seeking to force the Company to rescind the improper option grants. To receive more information regarding the investigation of Pernix Therapeutics please fill out the form below.

To receive more information, please fill out the form.

Pernix Therapeutics Holdings, Inc. Information Request Form

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.

This submission does not create an attorney-client relationship. If we believe that you might be an appropriate lead plaintiff, we will contact you to discuss whether to establish an attorney-client relationship.

This letter confirms that you have retained Levi & Korsinsky, LLP to represent you as a named plaintiff in a shareholder action involving Pernix Therapeutics Holdings, Inc.

We agree to advance all expenses in the litigation, which means that you are not liable to pay any of the expenses of the lawsuit, whether attorneys' fees or costs. Regardless of the result, we will never ask you to directly pay for any attorneys' fees or costs. Should we obtain a favorable result, we may ask the court to award us compensation to be paid by the defendants or as a portion of any class benefit, but, again, we will never ask you to directly pay any of the costs of this litigation.

As the client you are entitled to direct the litigation in any way you deem proper, and may at any time order us to dismiss the case or opt-out. Should you choose to do so, we will never ask you to reimburse us directly for any legal fees or expenses. During the course of this litigation, we may employ and/or work with other law firms to prosecute your case.

We look forward to representing you and other Pernix Therapeutics Holdings, Inc. shareholders.

Sincerely,

Levi & Korsinsky,LLP

Joseph Levi

AGREED: Sign Name Clear